SinoTau
Beijing
About SinoTau
SinoTau is a total solution provider specializing in generic drugs and innovative drugs. They provide cardiovascular fields, neurodegeneration fields, and tumor fields. The company specializes in the early development of antibody biopharmaceuticals and is researching a variety of medicines for use in treating cancers, neurological illnesses, and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $282.2M
- Funding stage: M&A
- Last round: Series E (Jul 2023)
- Website: sinotau.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sinotau-24694 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.